Paris Biofoundry

About Paris Biofoundry

The Paris Biofoundry is a pioneering research platform that unites the expertise and cutting-edge technology of several prestigious institutions in the Île-de-France region, including Sorbonne Université, Université Paris Cité and Université Paris-Saclay, the Institut Micalis and Institut Curie, the Genopole cluster, and the CNRS, INSERM and INRAE institutions. This collaborative initiative aims to accelerate the field of synthetic biology, enabling the development of advanced biotechnologies and innovative solutions in health, environment, and industry. The Paris Biofoundry specializes in the engineering of biological systems at large scales. State-of-the-art infrastructure enables designing, building and testing of thousands of genetically engineered chassis in parallel. These resources enable scientists to conduct large-scale experiments with unprecedented precision and efficiency, fostering advancements in areas such as gene editing, fundamental gene characterization, protein production and improvement, and metabolic engineering. The Biofoundry also plays a critical role in education and training, offering specialized programs for students and researchers. By providing access to its facilities and fostering a collaborative environment, the platform helps to cultivate the next generation of leaders in synthetic biology and related fields. In addition to its scientific contributions, the Paris Biofoundry actively engages with industry partners to translate research findings into practical applications, or to co-develop R&D projects. This collaboration ensures that innovations developed within the Biofoundry have a tangible impact, contributing to the growth of the biotechnology sector in the region and beyond. Overall, the Paris Biofoundry stands at the forefront of the bioconvergence revolution, driving forward the integration of biological engineering and data science to address some of the most pressing challenges of our time.